BAC
Bank of America Corporation
BAC has a slight edge over BNS overall, supported by stronger modeled upside and stronger fundamentals.
BNS
The Bank of Nova Scotia
BNS's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BNS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
BNS's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like BNS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BNS in the historical PE scenario, which offers more potential upside but is not a forecast.
BNS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.8x | $44.63 | -52% |
| Fair | 12x | $58.69 | -37% |
| Expensive | 16x | $79.47 | -14% |
| Current | 18x | $92.66 | — |
Historical ranges are pointers, not guarantees.
BNS's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
BNS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BNS, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BNS has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus BNS up 52%.
BNS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $5.08 | +52% |
| Q1 2026 | $4.71 | +38% |
| Q4 2025 | $3.96 | -4.1% |
| Q3 2025 | $3.66 | -8.5% |
| Q2 2025 | $3.35 | -21% |
| Q1 2025 | $3.42 | -20% |
| Q4 2024 | $4.13 | +1.2% |
| Q3 2024 | $4.00 | -10% |
BNS earned $5.08 per share over the past year, up 52% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 4.2% for BNS.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BNS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $12.1B | -4.2% |
| Q1 2026 | $12.4B | -7.5% |
| Q4 2025 | $12.8B | -3.6% |
| Q3 2025 | $12.6B | -6.8% |
| Q2 2025 | $12.6B | -3.3% |
| Q1 2025 | $13.4B | +127% |
| Q4 2024 | $13.3B | +138% |
| Q3 2024 | $13.6B | +140% |
BNS's revenue is shrinking: $12.1B last quarter, down 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 20% | +5.6 points |
| Q1 2026 | 18% | +9 points |
| Q4 2025 | 16% | +4.1 points |
| Q3 2025 | 19% | +7.9 points |
| Q2 2025 | 14% | +14 points |
| Q1 2025 | 9% | -23 points |
| Q4 2024 | 12% | -7.2 points |
| Q3 2024 | 11% | -23 points |
BNS's operating margin was 20% last quarter, up 5.6 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with BNS at up 49%.
BNS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $11.9B | +619% |
| Q1 2026 | $8.9B | +168% |
| Q4 2025 | -$4.5B | -190% |
| Q3 2025 | $3B | -38% |
| Q2 2025 | $1.7B | +$2.6B |
| Q1 2025 | $3.3B | +120% |
| Q4 2024 | $5B | +54% |
| Q3 2024 | $4.9B | -70% |
BNS's free cash flow was $19.4B over the past year, up 30% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BNS.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BNS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BNS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -15M shares |
| 1 year | -1.3% | -16M shares |
| 3 years | +2.8% | +33M shares |
| 5 years | +0.6% | +7M shares |
| Available history | -1.7% | -21M shares |
BNS has 1.2B diluted shares, down 1.3% from a year ago, with $1.4B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $451.3M |
| Q1 2026 | $341M |
| Q4 2025 | $460.5M |
| Q3 2025 | $168.7M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BNS spent $1.4B buying back its own shares over the past year, after none the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BNS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 34.6x | High |
| Q1 2026 | 33.3x | High |
| Q4 2025 | 36.2x | High |
| Q3 2025 | 35.9x | High |
| Q2 2025 | 39.4x | High |
| Q1 2025 | 39.5x | High |
| Q4 2024 | 20.4x | High |
| Q3 2024 | 21.9x | High |
BNS's net debt is more than 20 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BNS.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BNS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.4 | Neutral |
| Stochastic | 63.5 | Neutral |
BNS's weekly RSI is 60 (neutral) and its Stochastic is 63 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BNS on valuation relative to its sector.
BNS PE vs Financial Services Sector
| Metric | BNS | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 40% above |
| PE % | 98 | 63 | 35 pts above |
BNS is trading at 18x earnings, a 40% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BNS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $92.0 | 0.8% above |
| 20 week MA | $90.7 | 2.1% above |
| 50 week MA | $81.7 | 13% above |
| 100 week MA | $68.7 | 35% above |
| 200 week MA | $58.7 | 58% above |
BNS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
BNS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.1 | $53.5 | -4.7% |
| 2021 | $53.5 | $69.8 | +30% |
| 2022 | $69.8 | $48.8 | -30% |
| 2023 | $48.8 | $48.7 | -0.3% |
| 2024 | $48.7 | $53.8 | +10% |
| 2025 | $53.8 | $74.2 | +38% |
| 2026 YTD | $74.2 | $92.7 | +25% |
BNS has the edge over BAC on returns for 2026, with the stronger performance.